We're proud to offer HealthFLD, Nanox AI's FDA cleared fully automated AI software for liver attenuation analysis from CT scans for non-invasive assessment. Early detection can save lives! Learn more: https://brnw.ch/21wKzrs On #InternationalNASHDay, we raise awareness about the global public health crisis of fatty liver disease, affecting over 115 million people worldwide. NASH is nonalcoholic steatohepatitis, the most severe form of nonalcoholic fatty liver disease (NAFLD), a condition in which the liver builds up excessive fat deposits, often causing cirrhosis that might lead to liver failure. #FattyLiverDisease #NASHDay #NASH #Innovation
Nanox AI’s Post
More Relevant Posts
-
May is #VisionHealthMonth. Hear from our trainees on their research on vision-related diseases. Victor Pham Truong is an MSc student in Dr. Valerie Wallace's lab at the Donald K. Johnson Eye Institute, University Health Network. His research focuses on studying #photoreceptor transplantation, by connecting #neurons and growing #axons to treat #vision illnesses and #blindness. #TraineeTuesday #KrembilResearchDay
To view or add a comment, sign in
-
Can all-cause mortality in patients with Metabolic dysfunction-associated steatotic liver disease (MASLD) be predicted in advance using data from previous hospital stays? That was the question we set out to answer five years ago with Tim Kendall and Jonathan Fallowfield through the INTErPRET-NAFLD project. It turns out, yes it can. With our collaborators, the Bering team has demonstrated that a Transformer Neural Network can be trained on 12 years of clinical history to achieve an accurate prediction of risk of all-cause mortality in patients with MASLD up to three years in advance. We hope that extrapolation of this technique to population-level data can enable scalable and accurate risk stratification to identify people most likely to benefit from anticipatory health care and personalized interventions. You can read the full findings through the Annals of Hepatology: https://lnkd.in/edNj4wiF I'm incredibly greatful to the SteatoSITE, Precision Medicine Scotland Innovation Centre, and the West of Scotland Safe Haven teams for their support. And of course special thanks to Lynn McMahon, Marian McNeil, and Charlie Mayor for putting up with me over the last few years! #MASLD #MachineLearning #ClinicalArtificialIntelligence #BraveAI
To view or add a comment, sign in
-
INTErPRET-NAFLD project: Research team has demonstrated that a Transformer Neural Network can be trained on 12 years of clinical history to achieve an accurate prediction of risk of all-cause mortality in patients with MASLD up to three years in advance..!
Can all-cause mortality in patients with Metabolic dysfunction-associated steatotic liver disease (MASLD) be predicted in advance using data from previous hospital stays? That was the question we set out to answer five years ago with Tim Kendall and Jonathan Fallowfield through the INTErPRET-NAFLD project. It turns out, yes it can. With our collaborators, the Bering team has demonstrated that a Transformer Neural Network can be trained on 12 years of clinical history to achieve an accurate prediction of risk of all-cause mortality in patients with MASLD up to three years in advance. We hope that extrapolation of this technique to population-level data can enable scalable and accurate risk stratification to identify people most likely to benefit from anticipatory health care and personalized interventions. You can read the full findings through the Annals of Hepatology: https://lnkd.in/edNj4wiF I'm incredibly greatful to the SteatoSITE, Precision Medicine Scotland Innovation Centre, and the West of Scotland Safe Haven teams for their support. And of course special thanks to Lynn McMahon, Marian McNeil, and Charlie Mayor for putting up with me over the last few years! #MASLD #MachineLearning #ClinicalArtificialIntelligence #BraveAI
To view or add a comment, sign in
-
Precision Medicine: A Beacon of Hope for Rare Diseases! Precision medicine is revolutionizing the treatment of rare diseases by tailoring therapies to individual genetic profiles. This personalized approach enhances accuracy, improves outcomes, and offers new hope for patients. Discover how this cutting-edge field is transforming healthcare! 🧬💊 #PrecisionMedicine #RareDiseases #PersonalizedHealthcare
To view or add a comment, sign in
-
𝗛𝗼𝘄 𝗠𝗼𝗹𝗲𝗰𝘂𝗹𝗮𝗿 𝗠𝗲𝗱𝗶𝗰𝗶𝗻𝗲 𝗶𝘀 𝗧𝗿𝗮𝗻𝘀𝗳𝗼𝗿𝗺𝗶𝗻𝗴 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 Molecular medicine is revolutionizing healthcare by allowing for: 𝗣𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻 𝘁𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁𝘀: Tailored to your unique biology for better outcomes. 𝗘𝗮𝗿𝗹𝘆 𝗱𝗶𝘀𝗲𝗮𝘀𝗲 𝗱𝗲𝘁𝗲𝗰𝘁𝗶𝗼𝗻: Catching illness before symptoms appear. 𝗡𝗲𝘄 𝘁𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀: Targeting specific molecules to fight diseases in new ways. 𝗜𝗺𝗽𝗿𝗼𝘃𝗲𝗱 𝗽𝗿𝗲𝘃𝗲𝗻𝘁𝗶𝗼𝗻: Identifying genetic risks to take proactive steps towards health. #molecularmedicine #futureofhealthcare #personalizedmedicine #precisionhealth #healthcareinnovation
To view or add a comment, sign in
-
The future of medicine is here! Adding genetic data to electronic health records can provide a more comprehensive picture of a patient’s health, leading to better diagnosis and treatment. #EHR #healthcareinnovation #genomics #futureofmedicine #digitalhealth #patientcare #healthcareIT #innovation #medicalscience #DNAtesting #genomicsmedicine #preventivehealthcare #pharmacogenomics #geneticcounseling
To view or add a comment, sign in
-
Today on #WorldLiverDay, we acknowledge the vital role the liver plays in maintaining our health and well-being. As we focus on #LiverHealth, advancements in analytical technologies contribute significantly to our understanding and ability to diagnose liver-related conditions. At #Shimadzu, we're committed to advancing liver health research, and one of the tools utilised is Liquid Chromatograph Mass Spectrometry #LCMSMS. This cutting-edge technology allows us to precisely analyze #BileAcids, and crucial biomarkers for liver function assessment and disease diagnosis. 💡Explore how our 𝙇𝘾-𝙈𝙎/𝙈𝙎 𝙈𝙚𝙩𝙝𝙤𝙙 𝙋𝙖𝙘𝙠𝙖𝙜𝙚 𝙛𝙤𝙧 𝘽𝙞𝙡𝙚 𝘼𝙘𝙞𝙙𝙨 boosts liver health research and clinical diagnostics 🔗 https://lnkd.in/dJxM4nAG Together, let's continue to innovate and raise awareness about Liver Health to ensure healthier lives for all 🛡️
To view or add a comment, sign in
-
Managing Director @ Terminal 4 Communications / WATHT member | Medical and Scientific Content Development
Amazing how the flow of discoveries in this field gets more and more relevant..
MBBS, LLB(Hons), MHSM, MBA, PhD, FRACMA - President Elect of Royal Australasian College of Medical Administrators, national Director of Medical Services at Calvary Health Care
Scientists discover a potential way to repair #synapses damaged in #Alzheimersdisease. In laboratory mice that have a condition mimicking human #Alzheimer’s disease, they found that a protein #KIBRA can reverse the #memory impairment associated with this type of #dementia. (Journal of Clinical Investigation, 1 Feb 2024) Source in comments.
To view or add a comment, sign in
-
Good Gill Health ! Vital for the fish of course, and important for producers to understand !
A significant proportion of gill pathology seems to be due to non-infectious causes. Vascular damage in gills is one of our most frequent observations in histopathology samples and exposure to harmful plankton is often a suspected cause. At Gill Health Initiative in Oslo 25th to 26th October, Histopathology Manager in Pharmaq Analytiq, Marianne Kraugerud will present an overview of the current trends in gill disease. #pharmaqanalytiq #wemakeaquacultureprogress https://lnkd.in/etkUSzbU
To view or add a comment, sign in
-
Why is there therapeutic inertia in addressing cardiovascular disease in the Asia-Pacific region? The lack of robust data on populations across the Asia-Pacific drives this inertia. Socioeconomic, cultural, genetic, and healthcare-related factors lead to diverse cardiovascular risks and therapeutic responses, yet these populations are underrepresented in clinical trials. This gap limits the translation of study results to broader patient populations, hindering effective treatment strategies. At Metadvice, we address these issues through our NN-enabled cohort management and point of care solutions that optimise therapies based on patients' unique phenotypes. By providing healthcare professionals with precise, personalised treatment options, we bridge the data gap and improve patient outcomes. #PrecisionMedicine #HealthcareInnovation #CardiovascularHealth #PharmaR&D #AsiaPacificHealth
To view or add a comment, sign in
15,672 followers